Menu
GeneBe

KIF1C

kinesin family member 1C, the group of Kinesins

Basic information

Region (hg38): 17:4997949-5028401

Previous symbols: [ "SAX2" ]

Links

ENSG00000129250NCBI:10749OMIM:603060HGNC:6317Uniprot:O43896AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • spastic ataxia 2 (Moderate), mode of inheritance: AR
  • spastic ataxia 2 (Strong), mode of inheritance: AR
  • spastic ataxia 2 (Supportive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Spastic ataxia 2, autosomal recessiveARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic24319291; 24482476

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the KIF1C gene.

  • Spastic ataxia 2 (416 variants)
  • not provided (151 variants)
  • Hereditary spastic paraplegia (63 variants)
  • Inborn genetic diseases (62 variants)
  • not specified (38 variants)
  • KIF1C-related condition (2 variants)
  • Abnormal central motor function (1 variants)
  • Intellectual disability (1 variants)
  • Cerebellar ataxia (1 variants)
  • Microcephaly (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the KIF1C gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
4
clinvar
108
clinvar
15
clinvar
127
missense
1
clinvar
5
clinvar
199
clinvar
12
clinvar
3
clinvar
220
nonsense
3
clinvar
2
clinvar
1
clinvar
6
start loss
1
clinvar
1
frameshift
6
clinvar
2
clinvar
2
clinvar
10
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
1
clinvar
2
clinvar
3
splice region
1
18
21
3
43
non coding
2
clinvar
76
clinvar
37
clinvar
115
Total 11 12 209 196 55

Highest pathogenic variant AF is 0.00000657

Variants in KIF1C

This is a list of pathogenic ClinVar variants found in the KIF1C region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-4998136-C-G not specified Likely benign (Aug 07, 2017)511252
17-4998169-G-C not specified Benign (Nov 24, 2017)383986
17-4998172-G-A not specified Likely benign (Feb 02, 2018)390513
17-4999663-G-A Benign (Mar 28, 2022)1526316
17-4999857-C-T not specified Likely benign (Apr 05, 2017)508694
17-4999978-G-A not specified Likely benign (Feb 06, 2018)515316
17-5000100-T-C Benign (Sep 18, 2018)1238133
17-5000249-G-T Likely pathogenic (Oct 23, 2020)987476
17-5000256-G-T Spastic ataxia 2 • Inborn genetic diseases Uncertain significance (Jan 17, 2024)1936541
17-5000260-C-T Spastic ataxia 2 Likely benign (Aug 10, 2022)565364
17-5000261-G-A Spastic ataxia 2 Benign (Mar 02, 2023)2732179
17-5000264-G-A Hereditary spastic paraplegia • Spastic ataxia 2 Conflicting classifications of pathogenicity (Aug 04, 2023)468851
17-5000283-C-T Spastic ataxia 2 Uncertain significance (Nov 27, 2017)536732
17-5000287-C-T Spastic ataxia 2 Likely pathogenic (Feb 23, 2023)2444164
17-5000294-C-T Spastic ataxia 2 Likely benign (Mar 20, 2023)2916862
17-5000297-C-T Spastic ataxia 2 Likely benign (Oct 05, 2020)1133426
17-5000299-G-A Spastic ataxia 2 Uncertain significance (Mar 31, 2022)2053151
17-5000322-T-C Spastic ataxia 2 Likely benign (Jun 02, 2022)2169104
17-5000366-C-T Spastic ataxia 2 Likely benign (Aug 10, 2023)1605549
17-5000367-G-A Spastic ataxia 2 Likely benign (May 20, 2022)2040309
17-5000694-G-A Likely benign (May 28, 2021)1326404
17-5000756-C-T Spastic ataxia 2 Likely benign (Nov 24, 2022)2144102
17-5000765-C-T Spastic ataxia 2 Likely benign (Jan 28, 2022)2052713
17-5000767-C-T Spastic ataxia 2 Likely benign (Jan 05, 2023)1646824
17-5000774-A-G Spastic ataxia 2 Uncertain significance (Feb 11, 2022)2051433

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
KIF1Cprotein_codingprotein_codingENST00000320785 2130454
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.7180.2821257150331257480.000131
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.405856880.8500.00004497021
Missense in Polyphen6497.6340.65551998
Synonymous-1.292952681.100.00001652266
Loss of Function5.521257.00.2110.00000323605

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001200.000119
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.0001400.000139
European (Non-Finnish)0.0001970.000185
Middle Eastern0.00005440.0000544
South Asian0.00009800.0000980
Other0.0003270.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Motor required for the retrograde transport of Golgi vesicles to the endoplasmic reticulum. Has a microtubule plus end- directed motility. {ECO:0000269|PubMed:9685376}.;
Disease
DISEASE: Spastic ataxia 2, autosomal recessive (SPAX2) [MIM:611302]: A neurologic disorder characterized by cerebellar ataxia, dysarthria, and variable spasticity of the lower limbs. Cognition is not affected. {ECO:0000269|PubMed:24319291, ECO:0000269|PubMed:24482476}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Vesicle-mediated transport;Membrane Trafficking;Kinesins;Factors involved in megakaryocyte development and platelet production;Hemostasis;COPI-dependent Golgi-to-ER retrograde traffic;Golgi-to-ER retrograde transport;Intra-Golgi and retrograde Golgi-to-ER traffic (Consensus)

Recessive Scores

pRec
0.163

Intolerance Scores

loftool
0.237
rvis_EVS
-0.65
rvis_percentile_EVS
16.14

Haploinsufficiency Scores

pHI
0.761
hipred
Y
hipred_score
0.637
ghis
0.567

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.719

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Kif1c
Phenotype
endocrine/exocrine gland phenotype; normal phenotype; reproductive system phenotype; immune system phenotype;

Gene ontology

Biological process
retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;microtubule-based movement;vesicle-mediated transport;cytoskeleton-dependent intracellular transport;anterograde neuronal dense core vesicle transport;retrograde neuronal dense core vesicle transport
Cellular component
endoplasmic reticulum;Golgi apparatus;kinesin complex;microtubule;axon;dendrite;neuron projection;axon cytoplasm
Molecular function
RNA binding;motor activity;microtubule motor activity;protein binding;ATP binding;microtubule binding;ATP-dependent microtubule motor activity, plus-end-directed;ATPase activity